HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
Languages: English, French, Portuguese and Spanish
Locations: Hackensack, NJ
Dr. Anne Renteria is senior medical director, Clinical Development – Hematology Oncology at Forma Therapeutics, New York, N.Y., and attending physician, Hematology Medical Oncology, BMT/CAR T-cell Therapies at Locum Tenens, Staff Care, AMN Healthcare. Prior to that she was medical director, Acute Leukemia & Stem Cell Transplant and Cellular Therapy Program, Hematology Oncology, at Lipson Cancer Institute, Rochester, N.Y. She has academic appointments at Tisch Cancer Institute, Mount Sinai School of Medicine and Boston University School of Medicine. She has been involved in a variety of clinical trials.
Federal University of Rio de Janeiro, RJ – Brazil, Doctor of Medicine, M.D.
Coney Island Hospital/HHC, Brooklyn, N.Y., intern, resident and chief resident, Internal Medicine Residency Program
University Hospital Clementino Fraga Filho Federal University of Rio de Janeiro, Rio de Janeiro, Brazil, Internal Medicine Residency Program
Hospital de Base, Brasilia – DF, Brazil, Internal Medicine Residency Program
Mount Sinai School of Medicine, New York, fellowship in blood and marrow transplantation
Maimonides Medical Center, Brooklyn, N.Y., hematology/oncology fellowship
University of Miami – Jackson Memorial Hospital, Miami, special immunology, HIV section
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.